Consistency between anticholinergic burden scales in patients with Sjögren's syndrome

Thorne, 2017, Sjogren's syndrome, Br J Hosp Med (Lond), 78, 438, 10.12968/hmed.2017.78.8.438 Brito-Zeron, 2016, Sjogren syndrome, Nat Rev Dis Primers, 2, 16047, 10.1038/nrdp.2016.47 Vivino, 2017, Sjogren's syndrome: clinical aspects, Clin Immunol, 182, 48, 10.1016/j.clim.2017.04.005 Baer, 2017, Sjogren syndrome and other causes of sicca in older adults, Clin Geriatr Med, 33, 87, 10.1016/j.cger.2016.08.007 Mariette, 2018, Primary Sjogren's syndrome, N Engl J Med, 378, 931, 10.1056/NEJMcp1702514 Bowman, 2018, Primary Sjogren's syndrome, Lupus, 27, 32, 10.1177/0961203318801673 Fernández-Ávila, 2018, Prevalencia y características demográficas del síndrome de Sjögren en Colombia, según información del Sistema Integral de Información de la Protección Social, Reumatol Clin Londoño, 2018, Prevalencia de la enfermedad reumática en Colombia, según estrategia COPCORD-Asociación Colombiana de Reumatología Estudio de prevalencia de enfermedad reumática en población colombiana mayor de 18 años, Rev Colomb Reumatol, 25, 245 Zero, 2016, Clinical practice guidelines for oral management of Sjogren disease: dental caries prevention, J Am Dent Assoc, 147, 295, 10.1016/j.adaj.2015.11.008 Foulks, 2015, Clinical guidelines for management of dry eye associated with Sjogren disease, Ocul Surf, 13, 118, 10.1016/j.jtos.2014.12.001 Price, 2017, The British Society for Rheumatology guideline for the management of adults with primary Sjögren's Syndrome, Rheumatology (Oxford), 56, 1828, 10.1093/rheumatology/kex375 Mayer, 2015, Different methods, different results – how do available methods link a patient's anticholinergic load with adverse outcomes?, Eur J Clin Pharmacol, 71, 1299, 10.1007/s00228-015-1932-x Salahudeen, 2015, Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review, BMC Geriatr, 15, 31, 10.1186/s12877-015-0029-9 Gerretsen, 2011, Drugs with anticholinergic properties: a current perspective on use and safety, Expert Opin Drug Saf, 10, 751, 10.1517/14740338.2011.579899 Fox, 2014, Effect of medications with anti-cholinergic properties on cognitive function, delirium, physical function and mortality: a systematic review, Age Ageing, 43, 604, 10.1093/ageing/afu096 Collamati, 2016, Anticholinergic drugs and negative outcomes in the older population: from biological plausibility to clinical evidence, Aging Clin Exp Res, 28, 25, 10.1007/s40520-015-0359-7 Tiisanoja, 2020, Anticholinergic burden and dry mouth in middle-aged people, JDR Clin Trans Res, 5, 62 Édgar, 2010, Métodos estadísticos de evaluación de la concordancia y la reproducibilidad de pruebas diagnósticas, Rev Colomb Obstet Ginecol, 61, 247, 10.18597/rcog.271 Watson, 2010, Method agreement analysis: a review of correct methodology, Theriogenology, 73, 1167, 10.1016/j.theriogenology.2010.01.003 Tiisanoja, 2018, Anticholinergic burden and dry mouth among Finnish, community-dwelling older adults, Gerodontology, 35, 3, 10.1111/ger.12304 Rudolph, 2008, The anticholinergic risk scale and anticholinergic adverse effects in older persons, Arch Intern Med, 168, 508, 10.1001/archinternmed.2007.106 Landis, 1977, The measurement of observer agreement for categorical data, Biometrics, 33, 159, 10.2307/2529310 Valladales-Restrepo, 2019, Potentially inappropriate anticholinergic drug prescriptions for patients with Sjögren's syndrome, J Transl Autoimmunity, 100007 Carnahan, 2006, The Anticholinergic Drug Scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity, J Clin Pharmacol, 46, 1481, 10.1177/0091270006292126 Boustani, 2008, Impact of anticholinergics on the aging brain: a review and practical application, Aging Health, 4, 311, 10.2217/1745509X.4.3.311 Naples, 2015, Concordance between anticholinergic burden scales, J Am Geriatr Soc, 63, 2120, 10.1111/jgs.13647 Pont, 2015, Measuring anticholinergic drug exposure in older community-dwelling Australian men: a comparison of four different measures, Br J Clin Pharmacol, 80, 1169, 10.1111/bcp.12670 Lertxundi, 2013, Expert-based drug lists to measure anticholinergic burden: similar names, different results, Psychogeriatrics, 13, 17, 10.1111/j.1479-8301.2012.00418.x Turro-Garriga, 2018, Measuring anticholinergic exposure in patients with dementia: a comparative study of nine anticholinergic risk scales, Int J Geriatr Psychiatry, 33, 710, 10.1002/gps.4844 Valladales-Restrepo, 2020, Consistency between anticholinergic burden scales in the elderly with fractures, PLOS ONE, 15, e0228532, 10.1371/journal.pone.0228532 American Geriatrics Society 2019 Updated AGS Beers Criteria(R) for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67:674–94. doi:10.1111/jgs.15767. O’Mahony, 2015, STOPP/START criteria for potentially inappropriate prescribing in older people: version 2, Age Ageing, 44, 213, 10.1093/ageing/afu145 Tsuboi, 2014, Primary and secondary surveys on epidemiology of Sjogren's syndrome in Japan, Mod Rheumatol, 24, 464, 10.3109/14397595.2013.843765 Tsukamoto, 2019, Ten-year observation of patients with primary Sjogren's syndrome: Initial presenting characteristics and the associated outcomes, Int J Rheum Dis, 22, 929, 10.1111/1756-185X.13464